Biogenic Monoamines

DBCAT000468Pharmacologic class

Biogenic amines having only one amine moiety. Included in this group are all natural monoamines formed by the enzymatic decarboxylation of natural amino acids. A DrugBank category of 46 drugs. 21 of them are approved.

Also known as: Monoamines, Biogenic
Drugs: 5-Methoxy-N,N-diisopropyltryptamine
5-methoxy-N,N-dimethyltryptamine
Adrenalone
Almotriptan
Alprazolam
Amphetamine
AT-13148
Avitriptan
Carbidopa
Diethyltryptamine
Dimethyltryptamine
Dipivefrin
Docarpamine
Donitriptan
Dopamine
Dopastatin
Dopexamine
Eletriptan
Epinephrine
Etryptamine
Frovatriptan
Histamine
Histamine glutarimide
Indopan
Levodopa
and 21 more with a free account

What you can answer from here — as of August 24, 2016

46DrugsEach linked to its full drug card

81Drug targetsEvery drug–target pair in the class, with bond type

7,336Marketed productsAcross the regions we cover, with dosage forms and routes

38Routes of administrationHow the drugs in this class are given

Which targets do Biogenic Monoamines share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account